It plans to pay for the acquisition with cash on hand. Arena has a potential treatment for ulcerative colitis in late-stage clinical testing that it also is testing to treat Chrohn’s disease....
The company is developing possible treatments is in dermatology and for acute heart failure. The sale price appears reasonable, given that Arena sales are expected to approach$ 3 billion in 2030, said Dr....
Vamil Divan, an analyst for Mizuho Securities USA. Divan likes Pfizer’s aggressive use of cash
综合
ABC新闻-商业新闻
2021-12-13 00:00:00.0